These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31352077)

  • 21. The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease.
    Singh D; Ravi A; Kane K; Schmalbach T; Hava DL
    Br J Clin Pharmacol; 2018 Sep; 84(9):2097-2105. PubMed ID: 29790581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials.
    Calverley PM; Könen-Bergmann M; Richard F; Bell S; Hohlfeld JM
    Adv Ther; 2016 May; 33(5):786-93. PubMed ID: 27084728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Respimat Soft Mist inhaler in COPD patients.
    Anderson P
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):251-9. PubMed ID: 18046862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.
    Singh S; Loke YK; Enright PL; Furberg CD
    BMJ; 2011 Jun; 342():d3215. PubMed ID: 21672999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R; Hänsel M; Buhl R; Rubin RA; Frey M; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2014 Oct; 74(15):1801-16. PubMed ID: 25300412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.
    Ferguson GT; Dalby RN
    Postgrad Med; 2018 Aug; 130(6):515-522. PubMed ID: 29972656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
    Zhang W; Xu L; Gao S; Ding N; Shu P; Wang Z; Li Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1471-1479. PubMed ID: 32606655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Molimard M; Raherison C; Lignot S; Balestra A; Lamarque S; Chartier A; Droz-Perroteau C; Lassalle R; Moore N; Girodet PO
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale.
    Wise RA; Anzueto A; Calverley P; Dahl R; Dusser D; Pledger G; Koenen-Bergmann M; Joseph E; Cotton D; Disse B
    Respir Res; 2013 Apr; 14(1):40. PubMed ID: 23547660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?
    Mathioudakis AG; Chatzimavridou-Grigoriadou V; Evangelopoulou E; Mathioudakis GA; Siafakas NM
    Pulm Pharmacol Ther; 2014 Aug; 28(2):91-7. PubMed ID: 24846455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.
    Hodder R; Price D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():381-90. PubMed ID: 19888356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers.
    Horhota ST; van Noord JA; Verkleij CB; Bour LJ; Sharma A; Trunk M; Cornelissen PJ
    AAPS J; 2015 Jul; 17(4):871-80. PubMed ID: 25794622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.
    Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Ora J; Matera MG
    Expert Rev Clin Pharmacol; 2015; 8(5):529-39. PubMed ID: 26294073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.
    Schmiedl S; Fischer R; Ibanez L; Fortuny J; Thürmann P; Ballarin E; Ferrer P; Sabaté M; Rottenkolber D; Gerlach R; Tauscher M; Reynolds R; Hasford J; Rottenkolber M
    Br J Clin Pharmacol; 2016 Feb; 81(2):379-88. PubMed ID: 26506314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR
    Wise RA; Calverley PM; Carter K; Clerisme-Beaty E; Metzdorf N; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():605-616. PubMed ID: 29497289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.